it's gets better by the day, page-2

AFT Corporation Ltd Suite 8, Level 6 Tel: Local 0500 810 888

A.BN. 003 004 701 062 3 Spring Street Fax: Local 0500 810 889

Sydney 2000 Tel: International +61500 810 888

New South Wales Fx: International +61500 810 889

MICROGENIX BREAKS INTO RUSSIAN HEALTH MARKET

Microgenix Technologies Ltd (A Joint Venture Company owned 50% by AFT Corporation Ltd) has

won its first order from the Academy of Medical Science of Russia, Oncology Centre, in Moscow.

This hospital is the most important centre for Oncology treatment within the Russian Federation.

Through a translator the Chief Doctor C. Markov has advised "We have proceeded with a test of your

equipment during first part of August 2003. Your MM60 has been installed in one of the surgery

operation rooms and tested for 10 full days. The results being really satisfying. We are convinced of

the efficiency of this device and the needs of such equipment are very essential.

Our hospital is equipped with 30 operation surgery rooms. We perform an average of 1000 monthly

of surgery operations. There are 3,000 doctors working in this hospital all trained and specialising in

the most up to date treatments against cancers.

The following departments are active:

Radio Surgery Techniques

Anti Cancer Children Treatment

Study and Research of Cancer Genesis

Available techniques:

Diagnostic Isotopic

Radio Surgery

Radiometrics and Dosimetry Clinic Treatments

Chemotherapy

Radio Chemotherapy

General Cancer Surgery

Following the test results, we decided to purchase your equipment during the month of September."

Mr Phillip Hall, Managing Director of Microgenix stated "These units were purchased with a view to

evaluating the units, the outcome of which has been very favourable. It will be a strategic reference

site for Microgenix for the health system in Russia."

The Microgenix Air Purification System represents a revolutionary advance in air

purification technology with its ability to rapidly capture and eliminate all harmful

pathogens and viruses tested to date. These include surrogates for Anthrax, Tuberculosis

and Smallpox

Released by:

AFT Corporation Ltd

Jeff Dalco

Managing Director

Direct Ph: +617 5471 1633

Direct Fx: +617 5471 1655

[email protected]

N O R T H A M E R I C A • A S I A – P A C I F I C • E U R O P